The approval of Sumitomo Pharma's Amchepry makes it the world's first commercialized medical product derived from iPS cells.

Monoclonal antibodies can block a key immune-related protein that drives the spread of brain cell damage in Parkinson's ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

Researchers have identified two proteins on the surface of neurons that may help drive the spread of Parkinson’s disease in ...

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...

Rebecca King Crews talks about how husband Terry first told her about a new FDA approval for focused ultrasound for treating ...

A novel, noninvasive brain stimulation approach—known as transcranial temporal interference stimulation (TIs)—may offer a new ...

Neuromodulation is an adjunct to medication for Parkinson’s symptom management, with growing interest in whether it could one ...

Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired Danish drugmaker Novo Nordisk's cell therapy candidate for ...

Terry Crews' wife, Rebecca King Crews, has been battling Parkinson's disease for 16 years. During an appearance on Monday's episode of the "Today Show," King Crews — who was diagnosed in 2015 - got ...